Introduction {#s1}
============

The POA coordinates multiple autonomic and behavioral responses that are critical for survival ([@bib30]). Notably, the POA controls sympathetic nerve activity (SNA) to brown adipose tissue (BAT) and modulates energy expenditure to defend core body temperature in response to ambient temperature changes ([@bib32]). In addition, the POA was further implicated in food intake modulation under a changing thermal environment ([@bib6]; [@bib4]). For example, rats with POA lesions had difficulty not only maintaining core temperature but also adjusting food intake upon ambient temperature changes ([@bib16]; [@bib15]). Despite its prominent role in regulating energy expenditure and implication in controlling food intake, the POA has not been investigated as an important brain area for body weight regulation ([@bib43]).

We have previously shown that POA Lepr neurons (Lepr^POA^ neurons) are stimulated by warm ambient temperature and mediate warm-adaptive responses, especially by decreasing both energy expenditure and food intake ([@bib44]). Importantly, chronic chemogenetic stimulation of these neurons in mice resulted in body weight loss caused by reduced food intake that surpassed the decrease in energy expenditure. This result proposes that the manipulation of POA neural circuits can affect body weight. Another Lepr-expressing neuronal population in the dorsomedial hypothalamus/dorsal hypothalamic area (DMH/DHA) is stimulated by ambient cold and leptin, and ablating *Lepr* in this area caused obesity in mice due to reduced energy expenditure without affecting food intake ([@bib45]; [@bib39]), revealing critical function of leptin signaling in the DMH/DHA on energy expenditure. Because both POA and DMH/DHA Lepr neurons control BAT thermogenesis to modulate energy expenditure, it is plausible that thermoregulation-related Lepr neurons integrate information on ambient temperature and internal energy state that is represented by leptin to fine tune the energy expenditure level. Taken together, we hypothesized that POA leptin signaling contributes to energy balance and body weight homeostasis by modulating energy expenditure and/or food intake in interaction with ambient temperature information. This possibility is further supported by studies showing that leptin is required for ambient temperature-dependent food intake adjustment ([@bib20]; [@bib19]).

In the current study, we investigated the role of POA leptin signaling by selective stimulation or knockdown of POA *Lepr* in mice. We demonstrate that POA leptin signaling contributes to body weight homeostasis by modulating energy expenditure level, specifically under a surplus energy state, in which circulating leptin level is high ([@bib34]). However, neither stimulation nor blockage of POA leptin signaling affected acute temperature-dependent metabolic adaptations. Finally, our study implicates Lepr^POA^ neurons in the HFD-induced increase of metabolic rate.

Results {#s2}
=======

Lepr^POA^ neurons respond heterogeneously to leptin {#s2-1}
---------------------------------------------------

First, we directly measured the effect of leptin on membrane potential of Lepr^POA^ neurons using whole-cell patch clamp recordings in *Lepr^EGFP^* reporter mice. In the absence of synaptic transmission blockers, a puff application of leptin depolarized most Lepr^POA^ neurons (56%), while less neurons were hyperpolarized (22%) or did not change the membrane potential (22%)([Figure 1A,C](#fig1){ref-type="fig"}). We obtained a similar result using a bath application of leptin ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Leptin treatment in the presence of synaptic transmission blockers (1 μM TTX +30 μM AP5 +30 μM CNQX +50 μM bicuculline) reduced the portion of depolarized neurons by 20%, indicating possible inputs from presynaptic Lepr neurons onto Lepr^POA^ neurons ([Figure 1B,D](#fig1){ref-type="fig"}). The percentage of hyperpolarized neurons remained unaffected. These results show that Lepr^POA^ neurons represent a heterogeneous population that responds differentially to leptin.

![Lepr^POA^ neurons respond heterogeneously to leptin.\
(**A--B**) Representative whole-cell current clamp recordings of Lepr^POA^ neurons showing three different responses to puff application of leptin in the absence (**A**) and the presence (**B**) of synaptic transmission blockers. (**C--D**) Membrane potential changes of individual Lepr^POA^ neurons in response to puff application of leptin in the absence (C, n = 23) and the presence (D, n = 25) of synaptic transmission blockers and the pie charts showing percetages of depolarization, hyperpolarization, and no change.\
10.7554/eLife.33505.004Figure 1---source data 1.Membrane potentials of individually recorded Lepr^GFP^ neurons at baseline and following leptin treatment used to categorize leptin response profiles in [Figure 1C,D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}.](elife-33505-fig1){#fig1}

POA leptin signaling transiently suppresses food intake {#s2-2}
-------------------------------------------------------

We tested next how stimulating POA Lepr affects food intake or energy expenditure. To this end, we chronically implanted a guide cannula in the POA to enable local delivery of leptin ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). First, we tested the effect of intra-POA leptin (0.05 or 0.5 pg) ([@bib18]; [@bib36]; [@bib37]) on normal dark cycle feeding (injections done 1 hr before the dark cycle) and measured food intake overnight ([Figure 2B](#fig2){ref-type="fig"}). Leptin significantly suppressed food intake in a dose-dependent manner during the first 3 hr after injection ([Figure 2C](#fig2){ref-type="fig"}). However, this leptin effect was transient and did not significantly affect total overnight food intake ([Figure 2D--E](#fig2){ref-type="fig"}). We confirmed that this leptin effect was not due to the leptin leakage to other areas, especially the arcuate nucleus of the hypothalamus (ARC), by staining for the phosphorylation of signal-transducer-and-activator-of-transcription-3 (pSTAT3), a marker for functional Lepr signaling ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}).

![POA leptin signaling suppresses food intake.\
(**A**) Schematic diagram showing the implantation of a chronic cannula in the POA of *Lepr^EGFP^* mice and a representative histological image showing the placement of the cannula. (**B**) Experimental scheme of testing POA leptin effect on food intake with BioDAQ. (**C**) Leptin injection into the POA suppressed dark-onset food intake for the first 3 hr after the injection (n = 8). There was a significant treatment effect during this period (repeated measures ANOVA, p=0.001). (**D**) POA leptin effect on food intake lasted only for the first 3 hr after the injection (n = 8). Bars with different letters denote statistical significance at p\<0.05 (repeated measures ANOVA, p=0.017). (**E**) Overnight food intake was similar between treatments (n = 8; repeated measures ANOVA, p=0.374). 3V, third ventricle; ac, anterior commissure; MnPO, median preoptic nucleus.\
10.7554/eLife.33505.007Figure 2---source data 1.Raw hourly food intake data over 13 hr and cumulative food intake data for time bins following intra-POA injections of PBS and leptin used to generate [Figure 2C,D,E](#fig2){ref-type="fig"}.](elife-33505-fig2){#fig2}

In the same mice, we investigated the role of POA leptin signaling (0.5 pg) during temperature-dependent metabolic adaptations using indirect calorimetry. Energy expenditure was compared between treatments at three different ambient temperatures (22, 30, and 10°C) during the light phase. While acute cold and warm exposure caused expected increases and decreases in energy expenditure, respectively, intra-POA leptin did not affect energy expenditure at any temperature condition tested ([Figure 3A--D](#fig3){ref-type="fig"}). Similarly, food intake increased during 6 hr of cold exposure and decreased during 6 hr of warm exposure but intra-POA leptin injection had no significant effect on temperature-dependent food intake adjustment ([Figure 3E](#fig3){ref-type="fig"}). These data collectively indicate that POA leptin signaling suppresses dark-onset food intake but is not involved in acute metabolic adaptations to ambient temperature changes.

![POA leptin signaling does not affect ambient temperature-dependent metabolic adaptations.\
(**A--C**) 24 hr energy expenditure from PBS and leptin injections (5 ng/ml, total 0.5 pg) are overlaid for RT (22°C), warm (30°C), and cold (10°C) (n = 8 each). Temperature was changed for 6 hr from 9 am to three pm. (**D**) 6 hr mean energy expenditure was compared between treatment conditions (paired *t*-test between PBS and leptin at each temperature). (**E**) Total food intake during the same 6 hr as in (**D**).\
10.7554/eLife.33505.009Figure 3---source data 1.Raw and mean energy expenditure for generation of [Figure 3A,B,C and D](#fig3){ref-type="fig"}; and food intake data used to generate [Figure 3E](#fig3){ref-type="fig"}.](elife-33505-fig3){#fig3}

POA leptin signaling is necessary for fasting-induced metabolic adaptations {#s2-3}
---------------------------------------------------------------------------

We then studied cell autonomous leptin function in Lepr^POA^ neurons by selective knockdown of *Lepr* in the POA (*Lepr^POA^* KD). We injected Cre-expressing adeno-associated virus (AAV-GFP:Cre) or green fluorescent protein-expressing control AAV (AAV-GFP) in the POA of *Lepr^flox/flox^* mice ([Figure 4A](#fig4){ref-type="fig"})([@bib31]). Retrospective histological analysis of pSTAT3 revealed that we obtained about 80% *Lepr* KD in the POA ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

![POA Lepr is necessary for fasting-induced hypometabolism.\
(**A**) A schematic diagram showing bilateral viral injection into the POA of *Lepr^flox/flox^* mice. (**B**) AAV-GFP:Cre injection resulted in about 80% reduction of pSTAT3^+^ cell numbers in the POA (n = 6 for AAV-GFP, n = 9 for AAV-GFP:Cre; independent *t*-test, p\<0.001). (**C--E**) Body weight, food intake, and energy expenditure were similar between groups throughout the study (repeated measures ANOVA followed by Bonferroni pairwise comparisons, p\>0.05). (**F**) Energy expenditure comparison between *ad lib* fed (n = 10), fasted +saline (n = 5), fasted +leptin (n = 5; 5 mg/kg, i.p.), and 2-week-long HFD feeding (n = 5). Leptin injection attenuated fasting-induced hypometabolism while HFD increased the metabolic rate. Bars with different letters denote statistical significance at p\<0.05 (one-way ANOVA followed by Bonferroni pairwise comparisons). (**G**) In *Lepr^POA^* KD mice, fasting did not decrease energy expenditure, thus leptin failed to attenuate fasting-induced hypometabolism (repeated measures ANOVA followed by Bonferroni pairwise comparisons, \*p\<0.05, \*\*p\<0.01).\
10.7554/eLife.33505.013Figure 4---source data 1.Individual cell counts used to generate [Figure 4B](#fig4){ref-type="fig"}; raw body weight and body weight changes used to generate [Figure 4C](#fig4){ref-type="fig"}; raw food intake and weight specific caloric intake used to generate [Figure 4D](#fig4){ref-type="fig"}; raw and mean energy expenditure used to generate [Figure 4E,F,G](#fig4){ref-type="fig"}.](elife-33505-fig4){#fig4}

Mice were fed regular chow diet (13.5 kcal% fat) and body weight and food intake were measured weekly for 3 weeks before viral injection and 10 weeks post-injection. Throughout the study, body weight and food intake did not differ between groups ([Figure 4C,D](#fig4){ref-type="fig"}). Energy expenditure was measured once before and three times after the viral injection but did not show any group difference at any stage ([Figure 4E](#fig4){ref-type="fig"}). Temperature-dependent changes in energy expenditure and food intake at cold (10°C) or warm (30°C) ambient temperature were also unaffected by POA *Lepr* KD, similar to POA Lepr stimulation (data not shown). We also did not see sex differences in any measurement ([Figure 4---figure supplement 2A--F](#fig4s2){ref-type="fig"}). Together, the results suggest that POA Lepr is not required for body weight homeostasis or ambient temperature-dependent metabolic adaptations.

However, based on leptin's well-known ability to inhibit fasting-induced hypometabolism in mice ([Figure 4F](#fig4){ref-type="fig"})([@bib11]; [@bib13]) and weight-reduced humans ([@bib40]), we further tested whether POA Lepr is involved in exogenous leptin effects on energy expenditure during a state of negative energy balance. Leptin was unable to prevent fasting-induced hypometabolism in *Lepr^POA^* KD mice contrary to control mice. This was primarily due to a failure to properly lower energy expenditure in response to a negative energy state during fasting ([Figure 4G](#fig4){ref-type="fig"}). As a result, there was no leptin-induced recovery of energy expenditure in *Lepr^POA^* KD mice.

POA leptin signaling is involved in body weight regulation under high fat diet {#s2-4}
------------------------------------------------------------------------------

The above data suggested that POA Lepr may be important for adjusting metabolic rate in response to internal energy state. To test this possibility, we used HFD because this diet results in a positive energy balance that leads to body weight gain despite increased energy expenditure, the opposite outcome of fasting ([Figure 4F](#fig4){ref-type="fig"}). In a new cohort of mice, we repeated the same experiment but the diet was switched from chow to HFD (58 kcal% fat) following viral injections. At the end of this study, we verified about 50% *Lepr* KD based on pSTAT3 immunohistochemical analysis ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Mice injected with AAV-GFP:Cre in the POA gained about twice as much weight as mice injected with AAV-GFP by 15 weeks after viral injection ([Figure 5A](#fig5){ref-type="fig"}). This increase in body weight was mainly due to increased fat mass, as shown by a trend for increased adiposity ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2A,B](#fig5s2){ref-type="fig"}). The level of pSTAT3 in the POA varied significantly in mice injected with AAV-GFP:Cre due to inherent variability of viral injections, which may explain the large standard errors for this group in [Figure 5A--B](#fig5){ref-type="fig"}. Thus, we correlated the body weight change at week 15 and the adiposity index at week 13 to POA pSTAT3^+^ cell numbers across all mice, and both parameters showed significant negative correlation with POA pSTAT3^+^ cell numbers ([Figure 5C,D](#fig5){ref-type="fig"}). These analyses imply that POA Lepr signaling is important for body weight control under HFD conditions. The increase in body fat and weight was not due to increased food consumption because mice from both groups ate the same amount of food throughout the study ([Figure 5E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2C](#fig5s2){ref-type="fig"}).

![POA Lepr is involved in body weight regulation under HFD.\
(**A**) *Lepr^POA^* KD mice gained greater body weight than control mice over 15 weeks on HFD (repeated measures ANOVA followed by Bonferroni pairwise comparisons, \*p\<0.05, \*\*p\<0.01). (**B**) There was a trend of higher adiposity index (fat mass/lean mass) in *Lepr^POA^* KO mice (the effect of virus type on adiposity index was tested by repeated measures ANOVA, p=0.141). (**C--D**) Body weigh change at week 15 and adiposity index at week 13 are negatively correlated with POA pSTAT3^+^ cell numbers (Pearson correlation). (**E**) Cumulative food intake during the entire study was similar between groups (repeated measures ANOVA followed by Bonferroni pairwise comparisons). (**F**) Energy expenditure is compared between time points within each group. Bars with different letters denote statistical significance at p\<0.05 (repeated measures ANOVA followed by Bonferroni pairwise comparisons). (**G**) Cumulative energy efficiency (body weight gain/food intake) showed a significant interaction between week and virus type (*F*~(11,319)~ = 2.518, p\<0.01, repeated measures ANOVA followed by Bonferroni pairwise comparisons, \*p\<0.05). (**H**) Total plasma T3 levels were not significantly different between groups (independent *t*-test, p=0.267). (**I**) Total plasma T3 levels showed a significant positive correlation with POA pSTAT3^+^ cell numbers (Pearson correlation).\
10.7554/eLife.33505.019Figure 5---source data 1.Raw data body weight, raw body composition, body weight changes, adiposity index and percent body composition used to generate [Figure 5A,G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2A and B](#fig5s2){ref-type="fig"}; food intake used to generate [Figure 5E andG](#fig5){ref-type="fig"}; raw and mean energy expenditure used to generate [Figure 5F](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2E](#fig5s2){ref-type="fig"}; energy efficiency used to generate [Figure 5G](#fig5){ref-type="fig"}; raw scoring and total number of estrous cycles used to generate [Figure 5---figure supplement 2l](#fig5s2){ref-type="fig"}.](elife-33505-fig5){#fig5}

Energy expenditure, measured once before and twice after viral injection, showed no significant group difference at any time point ([Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}). However, there was a trending decrease of energy expenditure in *Lepr^POA^* KD mice from week −3 to week 10 ([Figure 5F](#fig5){ref-type="fig"}), which resulted in a bigger energy expenditure reduction from week −3 to week 10, compared to control mice ([Figure 5---figure supplement 2E](#fig5s2){ref-type="fig"}). Still, these comparisons were not statistically significant, and the baseline energy expenditure at week 10 and POA pSTAT3^+^ cell number did not show a significant correlation ([Figure 5---figure supplement 2F](#fig5s2){ref-type="fig"}). A main caveat of the cross-sectional measurement of energy expenditure is that it is prone to miss a very small difference over a long period of time. Therefore, we used a more longitudinal measure that can reflect changes in energy expenditure, that is an energy efficiency expressed as body weight gain divided by food intake, cumulated throughout the entire study ([Figure 5G](#fig5){ref-type="fig"}). Energy efficiency also showed a weak but significant negative correlation with POA pSTAT3^+^ cell number ([Figure 5---figure supplement 2G](#fig5s2){ref-type="fig"}), suggesting that *Lepr^POA^* KD mice spent less energy per unit food consumed.

Because Lepr^POA^ neurons control BAT SNA, we first tested whether BAT function declined in *Lepr^POA^* KD mice. Expression of BAT function-related genes, *uncoupling protein 1 (Ucp1)*, *peroxisome proliferative activated receptor gamma, coactivator one alpha* (*Ppargc1a*, also known as *Pgc1a*), and *deiodinase 2* (*Dio2*) showed a trending decrease in *Lepr^POA^* KD mice ([Figure 5---figure supplement 2H](#fig5s2){ref-type="fig"}), and expression levels of these genes were not significantly correlated with the POA pSTAT3^+^ cell number (data not shown). Consistent with this result, there was slightly increased but statistically non-significant increase in fat accumulation in BAT in *Lepr^POA^ KD* mice ([Figure 5---figure supplement 3A](#fig5s3){ref-type="fig"}). We next examined if the thyroid axis was affected in *Lepr^POA^* KD mice because systemic leptin increases *thyrotropin releasing hormone* (*Trh*) gene expression ([@bib35]; [@bib17]; [@bib14]) and the POA has been implicated in TRH secretion ([@bib3]; [@bib29]). TRH secretion ultimately leads to thyroid hormone secretion and metabolic rate increase through both central and peripheral mechanisms ([@bib28]; [@bib33]). We found that plasma levels of total triiodothyronine (T3) was only slightly and not significantly lower in *Lepr^POA^* KD mice but significantly correlated with the POA pSTAT3^+^ cell number ([Figure 5H,I](#fig5){ref-type="fig"}), suggesting that POA Lepr stimulates the thyroid axis to modulate energy expenditure. To corroborate this result, we observed strong projection of Lepr^POA^ neurons to the paraventricular nucleus of the hypothalamus (PVH) in the field of TRH neurons ([Figure 5---figure supplement 4A--B](#fig5s4){ref-type="fig"}). Furthermore, when wheat germ agglutinin (WGA)-GFP, an anterograde transsynaptic tracer, was expressed in Lepr^POA^ neurons, we observed a rare case of its expression in a TRH neuron in the PVH ([Figure 5---figure supplement 4C--D](#fig5s4){ref-type="fig"}). However, intra-POA leptin injection (0.5 pg) in fasted mice failed to significantly elevate the total T3 level ([Figure 5---figure supplement 3B](#fig5s3){ref-type="fig"}), unlike the effect of systemic exogenous leptin in fasted mice on the thyroid hormone level ([@bib2]; [@bib1]). Consistent with POA *Lepr* KD under chow diet, ambient temperature-dependent metabolic adaptations in HFD-fed *Lepr^POA^* KD mice were not affected (data now shown).

Finally, POA Lepr is implicated in reproductive function in female mice by promoting nitric oxide synthesis that results in luteinizing hormone (LH) release ([@bib5]). We tested the effect of POA *Lepr* KD on female reproduction by measuring the estrous cycles for 19 days. The total number of cycles during this period was similar between groups ([Figure 5---figure supplement 2I](#fig5s2){ref-type="fig"}).

Discussion {#s3}
==========

Our study demonstrates that POA Lepr is involved in body weight regulation by modulating energy expenditure under negative (fasting) or positive (HFD) energy balance without affecting food intake, which may involve the control of BAT thermogenesis and thyroid hormone release. In contrast, a direct leptin injection into the POA transiently suppresses food intake without affecting energy expenditure. There are at least a couple of possible explanations for the seemingly contradictory phenotypes between the POA leptin injection and *Lepr* deletion. The first possibility is the well-known discrepancy of leptin function between below and above the normal physiological leptin level. The lack of leptin is generally considered a stronger signal than increasing leptin levels above normal circulating levels and biological responses do not show a linear relationship with the leptin concentration ([@bib22]). Another possibility is leptin's action on different cell types. In other words, the effect on food intake may be mediated by presynaptic Lepr expressed in neurons innervating the POA, likely at axon terminals, while the effect on energy expenditure may be mediated cell autonomously in POA Lepr neurons. A similar dual mode of leptin action exists in the ARC between agouti related neuropeptide (AGRP) and pro-opiomelanocortin (POMC) neurons, in which leptin suppresses the presynaptic inhibitory AGRP neuronal input onto POMC neurons and cell autonomously stimulates POMC neurons ([@bib10]). Our electrophysiological recordings also support this notion because leptin application in the presence of a cocktail of synaptic transmission blockers reduced the percentage of depolarized neurons compared to leptin application in the absence of blockers. The POA receives inputs from many Lepr-expressing neurons that could modulate food intake including AGRP and POMC neurons ([@bib42]).

Our POA *Lepr* KD study suggests that leptin acts on Lepr^POA^ neurons to modulate energy expenditure. However, because the energy expenditure phenotype of POA *Lepr* KD was only evident under fasting or HFD feeding and the effect was small, an acute intra-POA leptin injection in *ad lib* chow-fed mice may have failed to affect energy expenditure or induced undetectable changes. A more chronic leptin administration into the POA in food-restricted mice or *ob/ob* mice may be required in order to detect this small and specific leptin effect on energy expenditure. Furthermore, the retrospective histological pSTAT3 analysis showed that only a portion of POA Lepr had been stimulated by intra-POA leptin injection.

Because Lepr^POA^ neurons control ambient temperature-dependent metabolic adaptations ([@bib44]), we first speculated that POA leptin function may be involved in this aspect. This reasoning was further supported by the fact that leptin gene expression is inversely proportional to the SNA level to adipose tissue ([@bib41]; [@bib12]), which is controlled by ambient temperature and the POA. However, neither stimulation nor ablation of POA *Lepr* affected temperature-dependent adaptive changes in energy expenditure and food intake. Instead, energy expenditure was specifically affected when the internal energy state, which is reflected by circulating leptin levels, was low or high in *Lepr^POA^* KD mice. Although it seems counterintuitive that *Lepr^POA^* KD mice have higher energy expenditure during fasting than control mice, a similar discordance of leptin-linked physiology was reported for female reproduction. In female *Lepr^flox/flox^* mice injected with AAV-Cre in the POA, the baseline LH level was higher than that of control mice and leptin failed to further induce LH secretion ([@bib5]), reminiscent of our energy expenditure phenotype in *Lepr^POA^* KD mice during fasting. Despite the increased LH level in POA *Lepr*-ablated mice, female reproduction did not seem to be affected based on our study.

The exact cellular mechanism of how leptin affects Lepr^POA^ neuron functions is not clear due to small effect sizes and trending but statistically non-significant results for various measurements for energy expenditure. While Lepr^POA^ neurons strongly modulate BAT thermogenesis ([@bib44]), our results show no significant changes in BAT function in *Lepr^POA^* KD mice. However, data from BAT gene expression and histology all point toward small but blunted BAT function by *Lepr*^POA^ KD. The weak but significant positive correlation between POA STAT3 activation and plasma T3 is consistent with previous studies showing leptin's involvement in expression and secretion of TRH ([@bib3]; [@bib35]; [@bib29]) and ability to prevent the fasting-induced drop in the thyroxine level ([@bib2]). We have also observed strong projections of Lepr^POA^ neurons to the PVH in the field of TRH neurons, even though we found little evidence for direct synaptic connection from Lepr^POA^ neurons to TRH^PVH^ neurons. Nonetheless, these collective data do not prove that POA Lepr signaling modulates the thyroid axis. It requires further investigation if neuronal (thermosensory) and humoral (leptin) inputs to Lepr^POA^ neurons modulate energy expenditure through separate mechanisms.

Lastly, it is important to point out that our AAV-GFP:Cre injection into the POA achieved only about 50% *Lepr* KD on average in the HFD study. We believe this partial ablation of POA Lepr and inherent variability of viral injections contributed to relatively small effect sizes and big standard errors that rendered many measurement differences between groups statistically insignificant. Therefore, the contribution of POA leptin signaling to energy balance and body weight homeostasis may be underestimated in our study.

Our study is the first to link POA leptin signaling to body weight control. HFD promotes a higher metabolic rate and POA Lepr may be necessary for this HFD-induced increase in energy expenditure. Therefore, the loss of POA Lepr may have accelerated the body weight gain caused by HFD in *Lepr^POA^* KD mice. Our study also proposes a potential integration of environmental temperature information and internal energy state in the POA through neural and humoral routes, respectively. Even though acute temperature-dependent metabolic adaptations did not interact with POA leptin signaling, the long-term interaction still remains to be investigated.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                      Designation                                        Source or reference                                                               Identifiers                                                                            Additional information
  or resource                                                                                                                                                                                                                                                              
  -------------------------------------------- -------------------------------------------------- --------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ------------------------------------------------------------------
  strain, strain background (*M. Musculus*)    C57BL/6J                                           The Jackson Laboratory                                                            JAX: 000664; RRID: [IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)   

  genetic reagent (*M. Musculus*)              *Lepr^EGFP^*                                       Dr. Martin G. Myers, Jr., University of Michigan; PMID: 17021368                                                                                                         Full nomenclature: *Lepr^Cre/Cre^; Gt(ROSA)26Sor^tm2Sho/tm2Sho^*

  genetic reagent (*M. Musculus*)              *Lepr^flox/flox^*                                  Dr. Streamson C. Chua, Jr., Albert Einstein College of Medicine; PMID: 15389315                                                                                          

  genetic reagent (*Adeno-associated virus*)   AAV-GFP (AAV5-hSyn-EYFP)                           University of North Carolina Vector Core                                          UNC: AV4836                                                                            Titer: 4.0 × 10Exp12 vg/ml

  genetic reagent (*Adeno-associated virus*)   AAV-GFP:Cre (AAV5-hSyn-GFP:Cre)                    University of North Carolina Vector Core                                          UNC: AV6446                                                                            Titer: 5.1 × 10Exp12 vg/ml

  antibody                                     anti-pSTAT3 (Tyr705, rabbit polyclonal)            Cell Signaling                                                                    Cell Signaling: 9131RRID: [AB_331586](https://scicrunch.org/resolver/AB_331586)        (1:500)

  antibody                                     anti-GFP (chicken polyclonal)                      Abcam                                                                             Abcam: ab13970; RRID: [AB_300798](https://scicrunch.org/resolver/AB_300798)            (1:1000)

  antibody                                     anti-TRH (rabbit polyclonal)                       Dr. Eduardo A. Nillni, Brown University                                           EAN: pYE26                                                                             (1:1000)

  antibody                                     anti-UCP1                                          Abcam                                                                             Abcam: ab209483\                                                                       (1:4000)
                                                                                                                                                                                    RRID: [AB_2722676](https://scicrunch.org/resolver/AB_2722676)                          

  antibody                                     anti-rabbit IgG-biotin (donkey polyclonal)         ImmunoResearch Laboratories                                                       IRL: 711-065-152; RRID: [AB_2340593](https://scicrunch.org/resolver/AB_2340593)        (1:1000)

  antibody                                     anti-chicken IgY-DyLight 488 (donkey polyclonal)   ImmunoResearch Laboratories                                                       IRL: 703-486-155\                                                                      (1:200)
                                                                                                                                                                                    discontinued                                                                           

  antibody                                     anti-rabbit AlexaFluor 594 (donkey polyclonal)     ThermoFisher Scientific                                                           TFS: A-21207; RRID: [AB_141637](https://scicrunch.org/resolver/AB_141637)              (1:200)

  peptide, recombinant protein                 leptin (mouse recombinant)                         National Hormone and Peptide Program                                                                                                                                     <http://www.humc.edu/hormones>

  commercial assay or kit                      Milliplex Map Kit (plasma T3)                      Millipore Sigma                                                                   Millipore Sigma: RTHYMAG-30K                                                           

  commercial assay or kit                      Vectastain ABC kit                                 Vector Laboratories                                                               Vecotr Laboratories: PK-6100                                                           

  other                                        HFD (high fat diet for mouse)                      Research Diets                                                                    Research Diets: D12331                                                                 58 kcal% fat
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mice {#s4-1}
----

All experiments were approved by the Institutional Animal Care and Use Committee at Pennington Biomedical Research Center, Baylor College of Medicine, and Tulane University. Mice were housed at 22--24°C with a 12:12 light:dark cycle. Laboratory rodent diet (5001, LabDiet) and water were available *ad libitum* unless otherwise stated. *Lepr^EGFP^* and *Lepr^Cre^* mice were kindly provided by Dr. Martin G. Myers, Jr., University of Michigan ([@bib26]; [@bib24]) and *Lepr^flox/flox^* mice by Dr. Streamson C. Chua, Jr., Albert Einstein College of Medicine ([@bib31]). C57BL/6J mice were obtained from the Jackson Laboratory (stock \#000664).

Electrophysiology {#s4-2}
-----------------

*Lepr^EGFP^* mice were used for all neuronal activity recordings. Mice were deeply anesthetized with isoflurane and transcardially perfused with a modified ice-cold artificial cerebral spinal fluid (aCSF: 10 mM NaCl, 25 mM NaHCO~3~, 195 mM Sucrose, 5 mM Glucose, 2.5 mM KCl, 1.25 mM NaH~2~PO~4~, 2 mM Na-pyruvate, 0.5 mM CaCl~2~, 7 mM MgCl~2~) ([@bib9]). The mice were then decapitated, and the entire brain was removed. Brains was quickly sectioned in ice-cold aCSF solution (126 mM NaCl, 2.5 mM KCl, 1.2 mM MgCl~2~, 2.4 mM CaCl~2~, 1 mM NaH~2~PO~4~, 5.0 mM Glucose, and 21.4 mM NaHCO~3~) saturated with 95% O~2~ and 5% CO~2~. Coronal sections containing the POA (250 µm) was cut with a Microm HM 650V vibratome (Thermo Scientific). Then the slices were recovered in the aCSF at 34°C for 1 hr. Whole-cell patch clamp recordings were performed in the GFP-labelled mature POA neurons visually identified by an upright microscope (Eclipse FN-1, Nikon) equipped with IR-DIC optics (Nikon 40x NIR). Signals were processed using Multiclamp 700B amplifier (Axon Instruments), sampled using Digidata 1440A and analyzed offline on a PC with pCLAMP 10.3 (Axon Instruments). The slices were bathed in oxygenated aCSF (32--34°C) at a flow rate of approximately 2 ml/min. Patch pipettes with resistances of 3--5 MΩ were filled with solution containing 126 mM K-gluconate, 10 mM NaCl, 10 mM EGTA, 1 mM MgCl~2~, 2 mM Na-ATP and 0.1 mM Mg-GTP (adjusted to pH7.3 with KOH). Current clamp was engaged to test neural firing frequency and resting membrane potential (RM) at the baseline and after puff application of leptin (300 nM, 1 s). In some experiments, the aCSF solution also contained 1 μM tetrodotoxin (TTX) and a cocktail of fast synaptic inhibitors, namely bicuculline (50 μM, a GABA receptor antagonist), DAP-5 (30 μM, an NMDA receptor antagonist) and CNQX (30 μM, an AMPA receptor antagonist) to block the majority of presynaptic inputs. The values for RM and firing frequency were averaged within 2 min bin at the baseline or after leptin puff. The RM values were calculated by Clampfit 10.3. A neuron was considered depolarized or hyperpolarized if a change in membrane potential was at least 2 mV in amplitude and this response was observed after leptin application and stayed stable for at least 1 min.

Viruses and stereotaxic surgeries {#s4-3}
---------------------------------

Stereotaxic injection of AAV was performed as previously described ([@bib39]). Briefly, 12--14 week-old *Lepr^flox/flox^* mice were placed on a stereotaxic alignment system (1900, David Kopf Instruments) and maintained anesthetized by 2% isoflurane during surgeries. For the selective deletion of *Lepr* in the POA, AAV5-hSyn-EYFP (AAV-GFP, 4.0 × 10^12^ vg/ml) or AAV5-hSyn-GFP:Cre (AAV-GFP:Cre, 5.1 × 10^12^ vg/ml) was injected into the POA (AP:+0.6 mm, ML:±0.4 mm, DV: −5.2 mm; 200 nl or 400 nl total at 20 nl/30 s) bilaterally using a bilateral guide cannula and injector set (C235G, Plastics One). Both viruses were obtained from the vector core of the University of North Carolina at Chapel Hill and injection coordinates were based on the Paxinos mouse brain atlas ([@bib38]).

Stereotaxic injection of Ad-iZ/EGFPf ([@bib25]; [@bib23]) and Ad-iN/WED ([@bib27]) in the POA was performed similarly as described above with *Lepr^Cre^* mice. Ad-iZ/EGFPf (1.95 × 10^12^ PFU/ml) expresses membrane-targeted farnesylated EGFP while Ad-iN/WED (2.0 × 10^12^ PFU/ml) expresses anterograde transsynaptic WGA^GFP^ in the presence of Cre. Total 300--400 nl of viruses were injected. Brains were harvested by transcardial perfusion 10--14 days after viral injection.

For chronic cannulation in the POA, unilateral guide cannulas (C315GA, Plastics One) were implanted (AP:+0.58 mm, ML:±0 mm, DV: −4.2 mm). The guide cannulas were secured to the skull with dental cement and inserted with dummy cannulas (C315DC, Plastics One) to prevent contamination or clogs. 3-month-old male *Lepr^EGFP^* mice (n = 8) were used for group 1 and 3-month-old male C57BL/6J mice (n = 10) were used for group 2. Mice recovered for a week before being used for experiments.

POA leptin injection {#s4-4}
--------------------

Eight male *Lepr^EGFP^* mice (group 1) with intra-POA cannulas were acclimated to intra-POA injections for 4 days by injecting 100 nl saline (20 nl/20 s) once per day. The injection was carried out with a 1 μl Hamilton syringe (\#80100, Hamilton Company) that was connected to an injector (C315IA, Plastics One) that project 1 mm from the tip of the guide cannula. Thus, the injection depth was 5.2 mm from the bregma. During the acclimation, body weight of the mice was monitored daily and we ensured stabilization of the body weight before using mice for experiments.

We used BioDAQ (Research Diets) to test the effect of intra-POA leptin on regular chow intake. One hour before the dark cycle begins, 100 nl of PBS, 0.5 ng/ml leptin (0.05 pg), or 5 ng/ml (0.5 pg) leptin was injected into the POA as described above and 13 hr food intake (1 hr light cycle +12 hr dark cycle) was analyzed. Leptin was obtained from Dr. Parlow (National Hormone and Peptide Program, <http://www.humc.edu/hormones>). See [Figure 2B](#fig2){ref-type="fig"} for more information on the BioDAQ experimental design. Data for PBS injection were averages of 3 replicates and data for leptin injection were averages of two replicates for each concentration. The order of injections was counterbalanced and a rest day was placed between leptin injections.

To test the effect of intra-POA leptin on energy expenditure, we used the TSE system (TSE Systems). 100 nl of PBS or 5 ng/ml leptin was injected into the POA at CT 2 hr. Injections were carried out at RT (22°C), 30 and 10°C, and data for leptin injection were averages of two injections on separate days. Injections were counterbalanced in each temperature condition. When ambient temperature was changed from RT to either 30 or 10°C, the temperature was changed from CT 2 to CT 8 hr. Energy expenditure (kcal/hr/kg BW) and food intake during those 6 hr were compared between injections and temperature conditions.

On the final experimental day of group one mice, 100 nl of 5 ng/ml leptin was injected into the POA 1.5 hr before perfusion, followed by 100 nl of red-fluorescent Fluosphere (F8801, Thermofisher scientific) to mark the injection site. Mice were deeply anesthetized with isoflurane and transcardially perfused with ice-cold saline, followed by 10% formalin. Brains were removed and post-fixed in 10% formalin overnight at 4°C and cryoprotected in 30% sucrose in PBS.

For group 2, mice were fasted for 24 hr from CT 3 hr and injected with 100 nl PBS (n = 5) or leptin (5 ng/ml; n = 5) in the POA. Injections were done three times during this period at CT 3, 11, and 3 hr next day, and brains and trunk blood were harvested 1.5 hr after the final injection.

Selective *Lepr* KD in the POA {#s4-5}
------------------------------

### Study with regular chow diet {#s4-5-1}

About 3-month-old *Lepr^flox/flox^* mice were injected with AAV-Cre:GFP (5 males and four females) or AAV-GFP (4 males and two females) in the POA as described above. Weekly body weight was measured from 3 weeks before viral injections to 10 weeks post-injections. Weekly food intake was measured from 2 weeks before viral injections to 8 weeks post-injections. Food intake was measured by weighing food in the food hopper at the beginning and the end of each week. Big crumbs of food pellets on the cage floor were added to hopper pellets for measuring remaining food at the end of a week. Food intake was not measured when mice were in Comprehensive Laboratory Animal Monitoring System (CLAMS; Columbus Instruments) for indirect calorimetry during week −3, week 3, week 5 and week 10 to measure energy expenditure, locomotor activity, and respiratory exchange ratio (RER). Mice were maintained on regular chow diet (13.5 kcal% fat, 5001, LabDiet) throughout the study.

During the week five calorimetry study, leptin's effect on preventing fasting-induced hypometabolism was tested by fasting mice for 24 hr from CT 5 hr and injecting them with saline or leptin (5 mg/kg, i.p.) twice during that period, at CT 5 hr and 11.5 hr. The injection order was counterbalanced.

At the end of the study, leptin (5 mg/kg, i.p) was injected 1 hr before tissue harvest for immunohistochemical analysis of leptin receptor signaling in the POA ([@bib21]). We did not observe gender differences in any measurement, and thus presented combined data between males and females throughout the paper.

### Study with high fat diet {#s4-5-2}

3-month-old *Lepr^flox/flox^* mice were injected with AAV-Cre:GFP (6 males and 10 females) or AAV-GFP (6 males and nine females) in the POA. Food was switched from regular chow to high fat diet (58 kcal% fat, D12331, Research Diets) right after viral injections. Weekly body weight and food intake were measured from week −3 to week 15. Weekly food intake measurement was interrupted while mice were in TSE for indirect calorimetry at week −3, week 4 and week 10. Body composition was measured at week −3, week 1, week 4, week 7, week 10 and week 13 (Minispec LF110, Bruker). Adiposity index was calculated from fat mass divided by lean mass.

While mice were in TSE, the ambient temperature was maintained at 22°C and mice were tested for adaptive responses to ambient temperature changes. For a warm-adaptation testing, the ambient temperature was changed to 30°C from CT 11 hr to 1 hr next morning (total 14 hr). For a cold-adaptation testing, the ambient temperature was lowered to 10°C from CT 1 hr to 9 hr (total 8 hr). Different times of the day were used for two temperature conditions to facilitate the detection of changes in energy expenditure and food intake.

We checked the estrous cycle of female mice, starting at week 5 for 19 days by checking vaginal cytology as previously described ([@bib8]; [@bib7]). Briefly, we flushed the vaginal cavity of female mice with sterile saline (\~10 μl) 3--4 times and the final flush was collected on a glass slide. Vaginal cytology was observed unstained with a light microscope (Olympus BX51). The proestrus followed by the estrus was defined as one cycle ([@bib8]).

On the day of tissue harvest, mice were fasted for 4 hr before leptin (5 mg/kg, i.p.) was injected 1 hr prior to tissue harvest. Brain, liver, BAT, inguinal WAT, gonadal WAT, calf muscle, and trunk blood were collected for each mouse except for one male that was found dead in week 14. Collected peripheral tissues were sliced into multiple pieces and instantly frozen with dry ice.

Effect of systemic leptin injection and HFD on energy expenditure {#s4-6}
-----------------------------------------------------------------

Female C57BL/6J mice were used to test the effect of leptin during fasting or HFD on energy expenditure with CLAMS. For the fasting experiment, food was removed from the cage at CT 3.5 hr and leptin (5 mg/kg, i.p.; n = 5) or saline (n = 5) were injected at the same time. Average energy expenditure between the injection time and the end of the light cycle was compared between conditions (*ad lib* fed vs fasting +saline vs fasting +leptin). Energy expenditure after 2 weeks of HFD feeding was measured with female C57Bl/6J mice (n = 5).

Immunohistochemistry and histological analysis {#s4-7}
----------------------------------------------

Brains were sliced at 30 μm thickness into four series with a sliding microtome. pSTAT3 was visualized by diaminobenzene (DAB; 34065, ThermoFisher Scientific) following treatment with Vectastain ABC kit (PK-6100, Vector Laboratories) after incubation with a biotinylated secondary antibody. BAT was formalin fixed, paraffin processed, and sectioned at 5 μm for staining with hematoxylin and eosin (H and E) or with UCP1. UCP1 staining was visualized by DAB using Bond Polymer Refine Detection kit (DS9800, Leica). Stained slides were scanned using a NanoZoomer slide scanner (Hamamatsu) and lipid droplet area was computed on H and E images using a custom app within Visiopharm version 2017.7 (Visiopharm). Primary antibodies used in this study are rabbit anti-pSTAT3 (Tyr705, 9131, Cell Signaling; 1:500) and chicken anti-GFP (ab13970, Abcam; 1:1000), rabbit anti-TRH (Dr. Eduardo A Nillni, Brown University; 1:1000), and rabbit anti-UCP1 (ab209483, Abcam, 1:4000). Secondary antibodies are donkey anti-rabbit IgG-biotin (711-065-152, Jackson ImmunoResearch Laboratories; 1:1000) and donkey anti-chicken IgY-DyLight 488 (703-486-155, Jackson ImmunoResearch Laboratories; 1:200), and donkey anti-rabbit Alexa Fluor 594 (A-21207, ThermoFisher Scientific; 1:200).

Gene expression analysis {#s4-8}
------------------------

BAT RNA from the POA *Lepr* ablation study with HFD was purified with TRIzol Reagent (15596, ThermoFisher Scientific) and cDNA was synthesized with SuperScript VILO cDNA synthesis kit (11754050, ThermoFisher Scientific). The amount of transcripts for *Ucp1*, *Ppcargc1a*, and *Dio2* were measured using Taqman assays (ThermoFisher Scientific) by real-time PCR (7900HT, ThermoFisher Scientific), and *Gapdh* was used as a reference gene for relative quantification.

Total plasma T3 measurement {#s4-9}
---------------------------

Collected trunk blood from the POA *Lepr* ablation study was immediately mixed with 80 μl of 0.5 M EDTA and then with 15 μl of a protease inhibitor mixture (5 μl of protease inhibitor cocktail (p8340, Millipore Sigma)+5 μl of DPP IV inhibitor (DPP4, Millipore Sigma)+5 μl of 0.5 mg/ml Pefabloc (11429868001, Millipore Sigma)). Blood was centrifuged at 4°C for 10 min at 3000 rpm and then the upper plasma layer was collected and stored at −80°C. The total plasma T3 level was measured with Milliplex Map Kit (RTHYMAG-30K, Millipore Sigma).

Plasma of group two mice (n = 10) from the intra-POA leptin study was similarly prepared and the total T3 was measured the same way.

POA pSTAT3^+^ cell counting {#s4-10}
---------------------------

To determine the level of Lepr signaling in the POA of *Lepr^flox/flox^* mice injected with AAV-GFP or AAV-GFP:Cre, the total number of POA pSTAT3^+^ cells were counted. For each mouse, we pre-selected brain sections that contain rostral, medial, or caudal parts of the median preoptic areas that together encompass bregma 0.62--0.26 mm based on the Paxinos mouse brain atlas ([@bib38]). For distribution of Lepr neurons in the POA, refer to our previous study ([@bib44]). pSTAT3^+^ cells were counted by the count tool in Adobe Photoshop CS6 (Adobe Systems). Please note that pSTAT3^+^ cell numbers are only estimates because the POA areas used for cell counting are slightly different between mice in spite of our best effort to minimize the variability. The estimated pSTAT3^+^ cell numbers in the POA were correlated to various measurements (e.g. body weight).

Statistical analysis {#s4-11}
--------------------

Data are represented as mean ± SEM. All statistical analyses were done with SPSS 22/24 (IBM) and p\<0.05 was considered statistically significant. In all graphs, \*p\<0.05, \*\*p\<0.01, and \*\*\*p\<0.001. Some bar graphs used letters to indicate statistical significance between comparisons. For more detailed information, see results and figure legends.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Preoptic leptin signaling modulates energy balance independent of body temperature regulation\" for consideration by *eLife*. Your article has been favorably evaluated by Mark McCarthy (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Yu and colleagues examined the effects of manipulating leptin signaling in the preoptic area of the hypothalamus on body temperature, energy expenditure and energy balance. They report that preoptic leptin signaling regulates energy expenditure and body weight homeostasis. In contrast, leptin action in the preoptic area did not affect ambient temperature-dependent responses.

Having previously shown a role for POA leptin receptor neurons in thermal sensing and activating these cells decreases food intake and energy expenditure, the authors have now examined the role for direct leptin action on these cells for energy balance. Leptin depolarizes most POA LepRb neurons in acute slice preparations. Direct leptin infusion into the POA briefly decreases food intake, but does not alter energy expenditure (at a variety of temperatures) or energy balance. They also use AAV-cre to delete POA leptin receptors. While this does not alter food intake or energy balance on chow diet, leptin did not increase the energy expenditure when these animals were fasted (this may also have prevented the fall in energy expenditure with fasting). The knockout mice also gained more weight on HFD than did controls. In contrast, no alteration in energy expenditure was detected by calorimetry, the feed efficiency of these mice was increased, suggesting a subtle decrease in energy expenditure on HFD. Collectively, the studies provide some novel observations that will be of interest. However, several issues need to be addressed.

Essential revisions:

The biggest issue is noted by the authors relating to the mechanism of the effects to regulate energy expenditure. The negative data in the BAT is confusing. They suggest it may be related to the thyroid axis, though this correlation is somewhat weak. If the effect is mediated by changes in thyroid activity, some additional experiments supporting this seem to be lacking.

The photomicrographs demonstrating the AAV injections and pSTAT3 are too small for my eyes to see what the authors are presenting. Also, did the authors make maps/drawings of the injection sites and pSTAT staining?

The results are consistent with an effect of POA leptin on energy expenditure, especially when leptin decreases (as with fasting) or increases (as with HFD). The effect size is rather small, however. While the importance of POA leptin action is of some interest, the small effect size and the opposing effects of POA leptin as revealed by injection versus knockout are a source of confusion and limit the impact of the manuscript.

Can the authors be sure that the injected leptin only activates POA LepRb neurons? Mapping pSTAT3 plumes could shed light on this issue.

10.7554/eLife.33505.023

Author response

> Essential revisions:
>
> The biggest issue is noted by the authors relating to the mechanism of the effects to regulate energy expenditure. The negative data in the BAT is confusing. They suggest it may be related to the thyroid axis, though this correlation is somewhat weak. If the effect is mediated by changes in thyroid activity, some additional experiments supporting this seem to be lacking.

We agree with the reviewers that the body weight phenotype without a clear effect on energy expenditure is puzzling. However, we would like to remind the reviewers that the body weight changes are mild and small changes in BAT and thyroid function may be below detection levels.

To address this issue, we have now performed additional analysis of BAT histology with H and E staining, lipid area analysis, and UCP1 protein staining. While all parameters trended towards changes that are consistent with decreased thermogenic function in LepRb^POA^ knockdown (KD) mice, these changes did not reach statistical significance. This is consistent with our earlier data showing decreased expression of thermogenic BAT genes in LeprbPOA KD mice, which nevertheless did not reach statistical significance. Our new histological data are now included as Figure 5---figure supplement 3A.

We also performed additional studies to further investigate the link between POA leptin and total T3. Based on the work of Ahima RS et al.1996, we tested whether POA leptin would be sufficient to restore fasting-depressed circulating total T3 levels, using a new cohort of POA cannulated mice (n=10) for infusion of leptin into the POA. We found that POA leptin increased circulating free T3 levels in fasted mice, but these results did not reach statistical significance. We would like to point out that any intraparenchymal cannulation (here in the POA) will introduce more data variation due to cannula placements that explains the high standard error found in the leptin-treated group. These new data are now included in Figure 5---figure supplement 3B.

Finally, we tested whether LepRb^POA^ neurons project to the PVH and are synaptically connected to TRH neurons in the PVH. When we virally expressed farnesylated EGFP in LepRb^POA^ neurons, we observed strong fiber projection of LepRb^POA^ neurons to the PVH in close proximity of TRH neurons (Figure 5---figure supplement 4A-B). We also virally expressed WGA^GFP^, a transsynaptic anterograde tracer, in LepRb^POA^ neurons and found several WGA^GFP^-positive neurons in the PVH, confirming synaptic connectivity of LepRb^POA^ \> PVN circuits. However, only a single case of WGA^GFP^-TRH co-expression was found (Figure 5---figure supplement 4C-D), indicating that TRH neurons are likely an indirect target of LepRb^POA^ neurons.

In conclusion, we have now provided several additional and independent data that consistently point towards a blunted BAT thermogenesis and thyroid axis that explain the mild, but significant increase in body weight, but only the direct correlation of POA leptin responsiveness with T3 levels revealed significant changes. We have further highlighted in the Discussion that due to the small non-significant changes, we are unable to pinpoint the exact mechanism for the increased body weight, but that several experimental outcomes suggest a combination of a blunted BAT thermogenesis and thyroid axis (Discussion, fourth paragraph).

> The photomicrographs demonstrating the AAV injections and pSTAT3 are too small for my eyes to see what the authors are presenting. Also, did the authors make maps/drawings of the injection sites and pSTAT staining?

We moved previous Figure 4B to Figure 4---figure supplement 1A to enlarge the image. To help visualization of reduced pSTAT3 by AAV-GFP:Cre, we replaced the previous representative histological images for AAV-GFP:Cre to emphasize that the pSTAT3 level decreases only in areas of strong virus expression. We also included a diagram showing virus spreads of all 9 mice injected with AAV-GFP:Cre in Figure 4---figure supplement 1B. We did not include a map of pSTAT3 staining because pSTAT3 shows a complementary/reciprocal pattern to virus spread, as shown in Figure 4---figure supplement 1A.

We similarly enlarged images for AAV injections and pSTAT3 for the HFD study in Figure 5---figure supplement 1A and included virus spread for all 16 mice injected with AAV-GFP:Cre in Figure 5---figure supplement 1B. Previous Figure 5---figure supplement 1B-J are now separated as Figure 5---figure supplement 2.

> The results are consistent with an effect of POA leptin on energy expenditure, especially when leptin decreases (as with fasting) or increases (as with HFD). The effect size is rather small, however. While the importance of POA leptin action is of some interest, the small effect size and the opposing effects of POA leptin as revealed by injection versus knockout are a source of confusion and limit the impact of the manuscript.
>
> Can the authors be sure that the injected leptin only activates POA LepRb neurons? Mapping pSTAT3 plumes could shed light on this issue.

As shown in Figure 5---figure supplement 1A and in the Discussion, knockdown efficiency of LepRb by AAV-GFP:Cre is only about 50% in the HFD study, which may have contributed to the small effect size.

Observing different effects from POA leptin injection versus knockdown is not entirely surprising because numerous previous studies contrasted effects of low leptin (e.g. fasting, ob/ob) versus high leptin (e.g. IP or ICV leptin injection) on various physiological responses. In other words, leptin-mediated biological responses do not necessarily show a linear correlation to leptin concentration as mentioned in the first paragraph of the Discussion. We did not experimentally address the contrasting phenotypes observed by leptin injection versus knockdown, as this is outside the scope of this manuscript. However, as suggested by the reviewers, we verified that POA leptin injections did not cause leptin leakage to other hypothalamic sites like the ARC. We included representative pSTAT3 images in the POA and the ARC from intra-POA PBS, intra-POA leptin, and IP leptin (Figure 2---figure supplement 1B). We observed very few pSTAT3^+^ cells in the ARC of intra-POA leptin in all animals, thus ruling out leptin effects on the ARC.

[^1]: The authors declare no competing financial interests.
